Millennium Management’s PDS Biotechnology PDSB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-81,449
| Closed | -$108K | – | 6358 |
|
|
2025
Q2 | $108K | Buy |
81,449
+30,824
| +61% | +$41.9K | ﹤0.01% | 5504 |
|
|
2025
Q1 | $60.2K | Sell |
50,625
-75,791
| -60% | -$108K | ﹤0.01% | 5515 |
|
|
2024
Q4 | $206K | Sell |
126,416
-107,793
| -46% | -$285K | ﹤0.01% | 5292 |
|
|
2024
Q3 | $895K | Sell |
234,209
-147,202
| -39% | -$491K | ﹤0.01% | 4372 |
|
|
2024
Q2 | $1.12M | Buy |
+381,411
| New | +$1.22M | ﹤0.01% | 4028 |
|
|
2024
Q1 | – | Sell |
-12,717
| Closed | -$63.2K | – | 6528 |
|
|
2023
Q4 | $63.2K | Buy |
+12,717
| New | +$63.2K | ﹤0.01% | 5429 |
|
|
2023
Q2 | – | Sell |
-596,272
| Closed | -$3.67M | – | 6548 |
|
|
2023
Q1 | $3.67M | Buy |
596,272
+144,936
| +32% | +$1.19M | ﹤0.01% | 2889 |
|
|
2022
Q4 | $5.96M | Buy |
+451,336
| New | +$3.18M | ﹤0.01% | 2660 |
|
|
2022
Q3 | – | Sell |
-150,497
| Closed | -$549K | – | 7385 |
|
|
2022
Q2 | $549K | Buy |
+150,497
| New | +$715K | ﹤0.01% | 4874 |
|
|
2022
Q1 | – | Sell |
-91,770
| Closed | -$743K | – | 7333 |
|
|
2021
Q4 | $743K | Buy |
+91,770
| New | +$987K | ﹤0.01% | 4694 |
|
|
2021
Q2 | – | Sell |
-21,132
| Closed | -$96K | – | 6956 |
|
|
2021
Q1 | $96K | Buy |
+21,132
| New | +$85K | ﹤0.01% | 5696 |
|
|
2020
Q2 | – | Sell |
-67,235
| Closed | -$49K | – | 4494 |
|
|
2020
Q1 | $49K | Buy |
+67,235
| New | +$116K | ﹤0.01% | 3669 |
|
|
2018
Q4 | – | Sell |
-3,189
| Closed | -$52K | – | 4074 |
|
|
2018
Q3 | $52K | Sell |
3,189
-22,322
| -87% | -$401K | ﹤0.01% | 3806 |
|
|
2018
Q2 | $526K | Buy |
25,511
+24,595
| +2,685% | +$513K | ﹤0.01% | 3142 |
|
|
2018
Q1 | $22K | Sell |
916
-13,004
| -93% | -$3.5M | ﹤0.01% | 3566 |
|
|
2017
Q4 | $2.61M | Sell |
13,920
-2,136
| -13% | -$430K | ﹤0.01% | 2118 |
|
|
2017
Q3 | $3.45M | Buy |
16,056
+78
| +0.5% | +$16.1K | 0.01% | 1872 |
|
|
2017
Q2 | $3.28M | Sell |
15,978
-1,751
| -10% | -$345K | 0.01% | 1772 |
|
|
2017
Q1 | $3.23M | Buy |
17,729
+3,809
| +27% | +$754K | 0.01% | 1722 |
|
|
2016
Q4 | $3.48M | Sell |
13,920
-124
| -0.9% | -$28.2K | 0.01% | 1578 |
|
|
2016
Q3 | $2.92M | Buy |
14,044
+1,592
| +13% | +$315K | ﹤0.01% | 1679 |
|
|
2016
Q2 | $2.52M | Buy |
12,452
+2,479
| +25% | +$438K | 0.01% | 1664 |
|
|
2016
Q1 | $1.82M | Buy |
9,973
+882
| +10% | +$158K | ﹤0.01% | 1830 |
|
|
2015
Q4 | $2.27M | Buy |
+9,091
| New | +$2.93M | ﹤0.01% | 1837 |
|
Other funds holding PDSB
IWA
Millennium Management's PDSB Position: Q3 2025 in Review
Millennium Management sold out of PDS Biotechnology (PDSB) in Q3 2025, closing a stake of 81,449 shares — an estimated $108K sold.
Millennium Management first reported a position in PDSB in Q4 2015 and held it in 24 quarters. The position peaked at $5.96M in Q4 2022. 47 funds tracked by Wall St. Rank hold PDSB as of Q3 2025.
- Millennium Management reported no remaining PDS Biotechnology position as of Q3 2025 after selling out during the quarter.
- Millennium Management sold 81,449 PDS Biotechnology shares in Q3 2025, an estimated $108K.
- Millennium Management first reported a position in PDS Biotechnology in Q4 2015 and held it in 24 quarters.
- Millennium Management's PDS Biotechnology position peaked at $5.96M in Q4 2022.
- 47 funds tracked by Wall St. Rank held PDS Biotechnology as of Q3 2025.
Based on Millennium Management's 13F filing for Q3 2025, filed 14 Nov 2025.